End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
28.08 CNY | -1.20% |
|
-4.91% | +3.08% |
05-27 | Morgan Stanley Starts Pacific Shuanglin Bio-pharmacy at Overweight With 37 Yuan Price Target | MT |
05-23 | Pacific Shuanglin Bio-pharmacy's Unit Gets Nod to Trial Intravenous Human Immunoglobulin | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+3.08% | 2.86B | |
+1.43% | 94.45B | |
-1.71% | 38.9B | |
-12.83% | 32.56B | |
-12.14% | 15.98B | |
-0.68% | 13.82B | |
-12.63% | 11.34B | |
+163.45% | 9.81B | |
-53.23% | 9.67B | |
+3.52% | 8.91B |
- Stock Market
- Equities
- 000403 Stock
- News Pacific Shuanglin Bio-pharmacy Co., LTD
- Pacific Shuanglin Bio-pharmacy's Unit Gets Nod to Trial Intravenous Human Immunoglobulin